The Ernst Schering Foundation has honored cell biologist F.-Ulrich Hartl, director at the Max Planck Institute of Biochemistry in Martinsried near Munich, for his outstanding research on the role of chaperones in protein folding in living cells. The 50,000-euro Ernst Schering Prize is one of the most prestigious German science prizes. Professor Sies, who will give the presentation speech at the award ceremony, comments: “Franz-Ulrich Hartl’s outstanding research deserves the highest recognition. It combines fundamental new insights into the homeostasis of correctly folded proteins with new perspectives on the development and progression of neurodegenerative diseases, which may lead to innovative therapeutic approaches.” The celebratory award ceremony will take place on September 26, 2016, in Berlin. Just few weeks ago it was also announced that Hartl will receive, together with Arthur L. Horwich and Susan L. Lindquist, this years’ Albany Medical Center Prize, one of America’s most distinguished Prizes in Medicine.
Researchers at the Max Planck Institute of Biochemistry (MPIB) found out that the protein GCN1 plays a crucial role in maintaining a healthy protein balance and thus may help to prevent neurodegenerative diseases.